We found a positive association between TFAP2B and AP-1 expression in papillary thyroid carcinoma patients, but due to a few studies which assessed their expression, we assessed the expression of another biomarker which is JAZF1. Here, JAZF1 is linked to thyroid gland papillary carcinoma.